Epigenetic Reprogramming in Cancer
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The demonstration of induced pluripotency and direct lineage conversion has led to remarkable insights regarding the roles of transcription factors and chromatin regulators in mediating cell state transitions. Beyond its considerable implications for regenerative medicine, this body of work is highly relevant to multiple stages of oncogenesis, from the initial cellular transformation to the hierarchical organization of established malignancies. Here, we review conceptual parallels between the respective biological phenomena, highlighting important interrelationships among transcription factors, chromatin regulators, and preexisting epigenetic states. The shared mechanisms provide insights into oncogenic transformation, tumor heterogeneity, and cancer stem cell models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was demonstrated that ipilimumab induces the expression of EZH2, a key epigenetic enzyme that plays an important role in cellular plasticity (115-118).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [117]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Expression of a single transfected cDNA converts fibroblasts to myoblasts
Davis, R. L., Weintraub, H., & Lassar, A. B. (1987) · Cell · doi:10.1016/0092-8674(87)90585-x · Cited by 3,385
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Cited by
Items 401–500 of 702
Lu, Q., Gao, J., Tang, S., Li, Z., Wang, X., Deng, C., Hu, J., Tao, Y., & Wang, Q. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s272717 · Cited by 17
Enzymology of Mammalian DNA Methyltransferases
Jurkowska, R. Z., & Jeltsch, A. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11454-0_4 · Cited by 21
The epigenetic landscape of mesenchymal stem cell and extracellular vesicle therapy
Zhang, S., Zhang, Z., Sui, B., Zheng, C., & Fu, Y. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.03.008 · Cited by 24
Reprogramming of mesenchymal stem cells by oncogenes
Eid, J. E., & Garcia, C. B. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.05.005 · Cited by 23
Next-generation molecular genetics of brain tumours
Suvà, M. L., & Louis, D. N. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000027 · Cited by 19
Self-citationGenomic stability during cellular reprogramming: Mission impossible?
von Joest, M., Búa, S., & Li, H. (2016) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2016.01.001 · Cited by 18
Hu, H., Wang, Y., Li, Z., Zhu, Y., Zhang, W., Wang, D., Lin, T., Yang, J., Wang, Y., & Cheng, J. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0395-9 · Cited by 16
“Epigenetic abnormality is a hallmark of human cancer and greatly contributes to cancer initiation and progression [4].”
Disruption of circadian clockwork in in vivo reprogramming‐induced mouse kidney tumors
Ohashi, M., Umemura, Y. M., Koike, N., Tsuchiya, Y., Inada, Y., Watanabe, H., Tanaka, T., Minami, Y., Ukimura, O., Miki, T., et al. (2017) · Genes to Cells · doi:10.1111/gtc.12552 · Cited by 16
Impact of Epigenetics on Complications of Fanconi Anemia: The Role of Vitamin D-Modulated Immunity
Velleuer, E., & Carlberg, C. (2020) · Nutrients · doi:10.3390/nu12051355 · Cited by 18
“Accordingly, tumorigenesis is associated with major epigenetic changes like in embryogenesis and often the respective epigenomic program of early development is activated [13].”
BackgroundOrganotypic Culture of Acinar Cells for the Study of Pancreatic Cancer Initiation
Carrer, A., & Paoli, C. (2020) · Cancers · doi:10.3390/cancers12092606 · Cited by 21
A Diffusion-like Process Accommodates New Crypts During Clonal Expansion in Human Colonic Epithelium
Olpe, C., Khamis, D., Chukanova, M., Skoufou-Papoutsaki, N., Kemp, R., Marks, K., Tatton, C., Lindskog, C., Nicholson, A. M., Brunton-Sim, R., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.035 · Cited by 20
“jðr; tÞ 1⁄4 M 4pDt e r2 4Dt; (23) August 2021 Accommodation of New Crypts by Diffusion 559.”
BackgroundEpigenetic regulation of traf2- and Nck-interacting kinase (TNIK) in polycystic ovary syndrome.
Li, D., Jiao, J., Zhou, Y., & Wang, X. (2015) · PubMed · Cited by 16
Zayeri, Z. D., Parsi, A., Shahrabi, S., Kargar, M., Davari, N., & Saki, N. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03117-z · Cited by 19
“Histone modification (including acetylation and methylation), DNA methylation and small noncoding RNAs (sncRNAs), such as micro RNAs (miRNAs), have also recently been discovered to function as epigenetic factors [14].”
BackgroundChen, Y., Ai, L., Zhang, Y., Li, X., Xu, S., Yang, W., Jin, J., Ma, Y., Hu, Z., Zhang, Y., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01705-6 · Cited by 20
“Epigenetic modi fi cations (including DNA/RNA modi fi cations and histone modi fi cations) can cause reversible and heritable changes to speci fi c genes without changing their sequences [14].”
Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk of gastric cancer in Turkey
Gök, İ., Baday, M., Çetinkünar, S., Kilic, K., & Bilgin, B. Ç. (2014) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2014.4.7 · Cited by 15
“Th e frequency of T allele was reported to be fi ve times more prevalent in the controls compared to the cancer patients [21,26-27].”
ResultDesign, strategies, and therapeutics in nanoparticle-based siRNA delivery systems for breast cancer
Yan, C., Zhang, J., Huang, M., Xiao, J., Li, N., Wang, T., & Ling, R. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00278k · Cited by 16
Zhang, H., Fu, X., Su, X., & Yang, A. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5969 · Cited by 17
“Being a key hallmark of human cancer, aberrant epigenetic alternations including histone modification are significantly involved in multiple stages of oncogenesis (18).”
Li, X., Zhang, W., Song, J., Zhang, X., Ran, L., & He, Y. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0693-2 · Cited by 15
Xue, Y., Yang, Y., Tian, H., Quan, H., Liu, S., Zhang, L., Yang, L., Zhu, H., Wu, H., & Gao, Y. Q. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13127 · Cited by 16
Exome sequencing: what clinicians need to know
Sastre, L. (2014) · Advances in Genomics and Genetics · doi:10.2147/agg.s39108 · Cited by 20
“41 Methods for the study of whole-genome methylation that allow for the detailed study of this epigenetic information have been recently developed.”
Ishii, T., Akiyama, Y., Shimada, S., Kabashima, A., Asano, D., Watanabe, S., Ishikawa, Y., Ueda, H. R., Akahoshi, K., Ogawa, K., et al. (2022) · Cancer Science · doi:10.1111/cas.15615 · Cited by 14
“N(6)- methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis.”
BackgroundColonic Aging and Colorectal Cancer: An Unignorable Interplay and Its Translational Implications
Yin, Q., Qin, F., Gan, F., Zhao, G., Chen, R., Wen, Y., Hua, X., Zeng, F., Zhang, Y., Xiao, Y., et al. (2025) · Biology · doi:10.3390/biology14070805 · Cited by 18
Gender-Specific DNA Methylome Analysis of a Han Chinese Longevity Population
Sun, L., Lin, J., Du, H., Hu, C., Huang, Z., Lv, Z., Zheng, C., Shi, X., Zhang, Y., & Yang, Z. (2014) · BioMed Research International · doi:10.1155/2014/396727 · Cited by 14
Xenopatients 2.0: Reprogramming the epigenetic landscapes of patient-derived cancer genomes
Menéndez, J. A., Alarcón, T., Corominas-Faja, B., Cuyàs, E., López‐Bonet, E., Martín, Á. G., & Vellón, L. (2014) · Cell Cycle · doi:10.4161/cc.27770 · Cited by 15
“In this scenario, a more accurate description of the complex events that occur during tumor progression requires the incorporation of the potential for “cellular reprogramming” with the stochastic and CSC models.(24-30) Cancer, cellular plasticity, and cell fate reprogramming are highly intertwined processes consideri…”
BackgroundDifferentially DNA methylation changes induced in vitro by traffic-derived nanoparticulate matter
Lei, X., Muscat, J. E., Zhang, B., Sha, X., & Xiu, G. (2017) · Toxicology · doi:10.1016/j.tox.2017.11.005 · Cited by 15
Omori, H., Sato, K., Nakano, T., Wakasaki, T., Toh, S., Taguchi, K., Nakagawa, T., & Masuda, M. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02995-z · Cited by 17
Investigating the role of Sirtuins in cell reprogramming
Shin, J., Kim, J., Park, H., & Kim, J. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.10.172 · Cited by 14
“Cellular reprogramming goes through an intricate process that is similar to biological pathways of tumorigenesis (5).”
BackgroundThe Colonic Crypt: Cellular Dynamics and Signaling Pathways in Homeostasis and Cancer
Nguyen, A. L., Lausten, M. A., & Boman, B. M. (2025) · Cells · doi:10.3390/cells14181428 · Cited by 14
“…of chromatin regions associated with WNT target genes (such as those containing Lymphoid Enhancer Factor-1 (LEF1) and T-cell Factor (TCF) motifs), and decreased accessibility of regions linked to differentiation-promoting factors like KLF and HOX family transcription factors [101–103].”
Learning the cellular origins across cancers using single-cell chromatin landscapes
Bairakdar, M. D., Lee, W., Giotti, B., Kumar, A., Štancl, P., Wagenblast, E., Hambardzumyan, D., Polak, P. P., Karlić, R., & Tsankov, A. M. (2025) · Nature Communications · doi:10.1038/s41467-025-63957-3 · Cited by 17
“SCOOP accurately and robustly predicted AT2 and basal cells as the COO of LUAD and LUSC 44 , respectively, showing signi fi cantly higher feature importance than the next most predictive feature(Fig.1a,c;Mann-Whitneytest, p <10 (cid:1) 19 ).”
Bi, F., Li, D., Cao, C., Li, C., & Yang, Q. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-89 · Cited by 13
“expression of BRCA1 is correlated with AGTR1 levels In mammals, promoter methylation at CpG dinucleotides is an important feature regulating gene expression [18].”
BackgroundSánchez-Molina, S., Figuerola-Bou, E., Sánchez‐Margalet, V., de la Cruz‐Merino, L., Mora, J., de Álava, E., García-Domínguez, D. J., & Hontecillas‐Prieto, L. (2022) · Cancers · doi:10.3390/cancers14215473 · Cited by 16
“Epigenetics is critical to induce the proper environment for EWSR1-FLI1 establishment, as cells with higher plasticity will provide more significant opportunities for reprogramming by the oncogene [12,13].”
BackgroundBreast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis
Aylon, Y., Furth, N., Mallel, G., Friedlander, G., Nataraj, N. B., Dong, M., Hassin, O., Zoabi, R., Cohen, B., Drendel, V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34863-9 · Cited by 15
Su, Y., Liu, C., Lu, X., Chuang, H.-Y., Li, G., Shao, S., Kong, Y., Lee, J. W., Ng, R. H., Wong, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71349-4 · Cited by 14
Stem/progenitor cells and reprogramming (plasticity) mechanisms in liver, biliary tree, and pancreas
Reid, L. M. (2016) · Hepatology · doi:10.1002/hep.28606 · Cited by 13
Kim, J., Lee, S. C., Jang, J. H., Kim, M.-S., Lee, E. H., & Kim, Y. Z. (2016) · Journal of neurosurgery · doi:10.3171/2016.4.jns1652 · Cited by 13
Beyond gene dictation in oral squamous cell carcinoma progression and its therapeutic implications
Kumar, A., Sarode, S. C., Sarode, G. S., Majumdar, B., Patil, S., & Sharma, N. K. (2017) · Translational Research in Oral Oncology · doi:10.1177/2057178x17701463 · Cited by 15
“The recent findings suggest that the precedence of changes in OSCC, which may not be initially resistant against genotoxic drug treatment, however in course of time due to epigenetic heterogeneity accumulation, these cells eventually will acquire drug resistance capability.(11,13) Therefore, appreciable in vitro, prec…”
BackgroundKunos, C. A., & Coleman, C. N. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.02.225 · Cited by 13
Epigenomic technologies for deciphering circulating tumor DNA
Daniūnaitė, K., Jarmalaitė, S., & Kriukienė, E. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.07.002 · Cited by 13
Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer
Wei, T.-T., Lin, Y.-C., Lin, P.-H., Shih, J., Chou, C., Huang, W., Yang, Y., Hsiao, P., & Chen, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3489 · Cited by 14
“Transcription factor-mediated gene expression is regulated by histone modification, in which histone acetylation induces chromatin relaxation to facilitate this event [14].”
BackgroundTakeda, D., Hasegawa, T., Ueha, T., Iwata, E., Harada, R., Sakakibara, A., Kawamoto, T., Minamikawa, T., Sakai, Y., & Komori, T. (2017) · Anticancer Research · doi:10.21873/anticanres.11419 · Cited by 12
Early diagnostic potential of APC hypermethylation in esophageal cancer
Wang, B., Song, H., Jiang, H., Fu, Y., Ding, X., & Zhou, C. (2018) · Cancer Management and Research · doi:10.2147/cmar.s148677 · Cited by 14
Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation
Shoni, M., Lui, K. O., Vavvas, D. G., Muto, M. G., Berkowitz, R. S., Vlahos, N., & Ng, S.-W. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666140616130217 · Cited by 15
“Similarly, PKs play essential role as modulators of reprogramming and at the same time, they have been considered hallmark of oncogenesis [114, 115].”
BackgroundTgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancer
Zhao, W., Zhu, Q., Tan, P., Alagbala, A. A., Long, T., Long, W., Li, Q., Liu, P., Ning, B., Wang, H. Y., et al. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx052 · Cited by 12
“…to cancer cells, iPSCs have unlimited growth potential and premature termination of cellular reprogramming which leads to Wilms tumor-like neoplasia in the kidney (Ohnishi et al., 2014), providing further evidence of the intrinsic link between cellular reprogramming and cancer (Suva et al., 2013).”
BackgroundMalignant Peripheral Nerve Sheath Tumors Show Decreased Global DNA Methylation
Nix, J. S., Haffner, M. C., Ahsan, S., Hicks, J. L., Marzo, A. M. D., Blakeley, J. O., Raabe, E. H., & Rodríguez, F. J. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly076 · Cited by 13
Proteomics of Long‐Lived Mammals
Tombline, G., Gigas, J., Macoretta, N., Zacher, M., Emmrich, S., Zhao, Y., Seluanov, A., & Gorbunova, V. A. (2020) · PROTEOMICS · doi:10.1002/pmic.201800416 · Cited by 13
Wang, J., Shao, L., Wu, L., Ma, W., Zheng, Y., Hu, C., & Li, F. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13440 · Cited by 12
The Nucleosome Remodeling and Deacetylase Complex in Development and Disease
Basta, J. M., & Rauchman, M. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800802-7.00003-4 · Cited by 18
Periasamy, J., Muthuswami, M., Rao, D. B., Tan, P. B. O., & Ganesan, K. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.017 · Cited by 12
Srivastava, Y., Tan, D. S., Malik, V., Weng, M., Javed, A., Cojocaru, V., Wu, G., Veerapandian, V., Cheung, L. W. T., & Jauch, R. (2019) · FEBS Journal · doi:10.1111/febs.15076 · Cited by 12
Noberini, R., Robusti, G., Vai, A., Savoia, E. O., Jodice, M. G., Bertalot, G., Çat, B., Pallavicini, I., Bonizzi, G., Capra, M. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63745-z · Cited by 16
Epigenetic aberrant methylation of tumor suppressor genes in small cell lung cancer.
Wang, S., & Wang, Z. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.08.21 · Cited by 11
RetractedRecapitulation of patient-specific 3D chromatin conformation using machine learning
Xu, D., Forbes, A. N., Cohen, S. M., Palladino, A. C., Karadimitriou, T., & Khurana, E. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100578 · Cited by 11
Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors
He, R. L., Weng, Z., Liu, Y., Li, B., Wang, W., Meng, W., Li, B., & Li, L. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10633-y · Cited by 12
Triff, K., McLean, M. W., Konganti, K., Pang, J., Callaway, E. S., Zhou, B., Ivanov, I. V., & Chapkin, R. S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.009 · Cited by 11
“master transcription factors by promoter methylation and modification of histones and nonhistone proteins lead to genomic instability and perturb the expression of gene sets associated with cell adhesion and apoptosis (2-5).”
BackgroundZhang, Q., Lu, B., & Li, J. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.026 · Cited by 11
DNA methylation dysregulations in rheumatic heart valve disease
Shen, K., Liu, H., Jing, R., Yi, J., & Zhou, X. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0585-3 · Cited by 11
“methylation deregulation studies have focused on cancer and auto-immune disease [13, 14].”
BackgroundTargeting the immune milieu in gastrointestinal cancers
Turkes, F., Mencel, J., & Starling, N. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01710-x · Cited by 11
Eckersley-Maslin, M. A. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200873 · Cited by 13
Gu, X. Q., Peng, X., Zhang, H., Han, B. R., Jiao, M.-R., Chen, Q.-S., & Zhang, Q. (2022) · Pharmaceutical Fronts · doi:10.1055/s-0042-1749373 · Cited by 10
Chen, X., Li, R., Qiu, Y., Lin, F., Chen, S., Li, X., Sun, H., Jiang, G., Fang, H., Qin, J., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108577 · Cited by 11
Integration of epigenomics and metabolomics: From biomarkers discovery to personalized medicine
Baghel, R., Maan, K., Haritwal, T., & Rana, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85652-2.00002-6 · Cited by 14
Hong, Z., Li, H., Li, L., Wang, W., & Xu, T. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160003 · Cited by 10
“Several studies have suggested that both UTX and JMJD3 are the tumor suppressor in multiple cancer types [11–14], and the somatic loss-of -function mutations of UTX have been reported in different tumors [15], including RCC [13,16] and bladder cancer [17].”
Farahmand, L., Darvishi, B., Salehi, M., Kouchaksaraei, S. S., & Majidzadeh‐A, K. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1405426 · Cited by 10
“‘Epigenetic mutations’ refers to the stable and heritable alterations in genetic information without occurrence of any change in DNA sequence [32].”
BackgroundWang, S., Yu, Y., Fang, Y., Huang, H., Wu, D., Fang, H., Bai, Y., Sun, C., Yu, A., Fan, Q. W., et al. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.07.001 · Cited by 10
Yao, S., Wang, X., Guo, Z. G., & Wang, J. (2020) · Oncogene · doi:10.1038/s41388-020-01446-1 · Cited by 10
Induced Pluripotent Stem Cells from Cancer-Resistant Naked Mole-Rats
Miura, K., Oiwa, Y., & Kawamura, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65943-1_13 · Cited by 13
Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer
Fang, Y., Li, D., Cao, C., Li, C., & Li, T. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-188 · Cited by 10
“In mammals, promoter methylation at CpG dinucleotides is an important feature regulating gene expression [13].”
BackgroundUchiumi, F., Larsen, S. H., & Tanuma, S. (2015) · InTech eBooks · doi:10.5772/59588 · Cited by 12
The cause of cancer mutations: Improvable bad life or inevitable stochastic replication errors?
Алексеенко, И. В., Kuzmich, A. I., Pleshkan, V. V., Tyulkina, D. V., Zinovyeva, M. V., Костина, М. Б., & Sverdlov, E. D. (2016) · Molecular Biology · doi:10.1134/s0026893316060030 · Cited by 9
He, K., Zhang, S., Shao, L. L., Yin, J. C., Wu, X., Shao, Y. W., Yuan, S., & Yu, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.004 · Cited by 10
Song, S., Wang, L., Jiang, X., Liu, X., Li, S., Xie, S., & Lu, D. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110772 · Cited by 10
Affinity Reagents for Studying Histone Modifications & Guidelines for Their Quality Control
Kungulovski, G., Mauser, R., & Jeltsch, A. (2015) · Epigenomics · doi:10.2217/epi.15.59 · Cited by 13
Epigenetic Regulation in Heart Failure: Part I RNA
Salvo, T. G. D. (2015) · Cardiology in Review · doi:10.1097/crd.0000000000000071 · Cited by 9
Genetics and epigenetics of gliomas
Suvà, M. L. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.14018 · Cited by 12
Self-citationSbardella, G. (2019) · Topics in medicinal chemistry · doi:10.1007/7355_2019_78 · Cited by 10
Cassidy, J. W., & Bruna, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804010-2.00004-7 · Cited by 13
A Review of Complex Systems Approaches to Cancer Networks
Uthamacumaran, A. (2020) · Complex Systems · doi:10.25088/complexsystems.29.4.779 · Cited by 11
“GBM stemness and recurrence were also seen in exposure of differentiated glioma cells to ionizing radiation therapy.”
BackgroundInfluentialDhar, S. S., Brown, C. J., Rizvi, A., Reed, L., Kotla, S., Zod, C., Abraham, J., Abe, J., Rajaram, V., Chen, K., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115619 · Cited by 8
Zhou, Y., Jay, A., Burget, N. G., Friedrich, T., Yoon, S., Alsing, J., Nir, G., Grosschedl, R., Vahedi, G., & Faryabi, R. B. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01827-2 · Cited by 10
Reprogramming Cancer Cells to Antigen-presenting Cells
Ferreira, A. G., Zimmermannová, O., Kurochkin, I., Ascic, E., Åkerström, F., & Pereira, C. (2023) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4881 · Cited by 9
Park, J. W., Bae, S. J., Yun, J. H., Kim, S., & Park, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021101 · Cited by 9
“The reprogramming of hiPSCs has been reported to lead to the deletion of tumor suppressor genes, posing a hurdle for the clinical application of cell therapies [24,25].”
BackgroundZhou, Z., Chen, X., Wang, H., Ding, L., Wang, M., Li, G., & Xia, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-76326-9 · Cited by 8
“The enzyme complexes PRC2 and UTX/JMJD3 regulate H3K27me3 levels through methylation and demethylation, respectively 38 .”
BackgroundGiri, S., & Bader, A. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.08.001 · Cited by 9
“The iPS cells and cancer stem cell share several properties.(40,41) In 2013, some research created mouse iPS cells were created using the combination of some specific small molecules(42) only without using of any such reprogramming viral factors.”
BackgroundZhang, S., Wu, S., & Weimin, T. (2016) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2016125 · Cited by 9
Alagarswamy, K., Shinohara, K., Takayanagi, S., Fukuyo, M., Okabe, A., Rahmutulla, B., Yoda, N., Qin, R., Shiga, N., Sugiura, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25451 · Cited by 8
Rizvi, A., Merlin, M. A., & Shah, G. M. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174546 · Cited by 10
TET proteins and epigenetic modifications in cancers
Ciesielski, P., Jóźwiak, P., & Krześlak, A. (2015) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1186346 · Cited by 11
Epigenetic Regulation in Heart Failure: Part II DNA and Chromatin
DiSalvo, T. G. (2015) · Cardiology in Review · doi:10.1097/crd.0000000000000074 · Cited by 9
“The pathologic role of altered DNA methylation detected by a variety of validated methods has been best studied to date in cancer.(24) Human malignancies frequently exhibit changes in DNA methylation patterns, particularly relative genome-wide hypomethylation and site-specific hypermethylation.”
BackgroundKungulovski, G., Kycia, I., Mauser, R., & Jeltsch, A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2999-3_24 · Cited by 8
Sailer, M., Sarvepalli, D., Brégère, C., Fisch, U., Guentchev, M., Weller, M., Guzman, R. G., Bettler, B., Ghosh, A., & Hütter, G. (2016) · Journal of Visualized Experiments · doi:10.3791/54018 · Cited by 8
Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity
Cuyàs, E., Verdura, S., Fernández‐Arroyo, S., Bosch‐Barrera, J., Martín-Castillo, B., Joven, J., & Menéndez, J. A. (2017) · Oncotarget · doi:10.18632/oncotarget.21834 · Cited by 8
“To better approach the extreme complexity of the CSC model of cancer heterogeneity/plasticity, the concept of cell-state rather than genetically fixed cell-type would be applicable [11, 13, 37].”
MethodAlterations in DNA Methylation Resulting from Exposure to Chemical Carcinogens
Pogribny, I. P., Kobets, T., & Beland, F. A. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0025456 · Cited by 8
Yu, Y., Yu, X., Pan, B., Chan, H. M., Kanıskan, H. Ü., Jin, J. J., Cai, L., & Wang, G. G. (2025) · Science Advances · doi:10.1126/sciadv.ads7876 · Cited by 11
“Compared with genetic alterations, epigenetic aberrations are potentially reversible, allowing those malignant cell populations to regain the normal cell states ( 47 , 49 , 51 ).”
Molecular barriers to processes of genetic reprogramming and cell transformation
Chestkov, I. V., Khomyakova, E. A., Vasilieva, E. A., Lagarkova, M. A., & Киселев, С. Л. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914120037 · Cited by 8
CREPT Disarms the Inhibitory Activity of HDAC1 on Oncogene Expression to Promote Tumorigenesis
Cao, Y., Ning, B., Tian, Y., Lan, T., Chu, Y., Ren, F., Wang, Y., Meng, Q., Li, J., Jia, B., et al. (2022) · Cancers · doi:10.3390/cancers14194797 · Cited by 8
“To sustain growth and eventually progress to metastasis, tumors undergo several molecular alterations including gene mutations, epigenetic rewiring and the preferable transcription of specific genes [2,3].”
BackgroundTargeted nanotherapeutics in cancer
Shiekh, F. A. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s62468 · Cited by 7
Blakeley, J. O., Bakker, A. C., Barker, A., Clapp, D. W., Ferner, R. E., Fisher, M. J., Giovannini, M., Gutmann, D. H., Karajannis, M. A., Kissil, J. L., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38239 · Cited by 7
Chen, Y., Chen, C., Chien, C., Su, Y.-Y., Luo, S., & Li, S.-H. (2021) · BMC Cancer · doi:10.1186/s12885-021-08726-3 · Cited by 8
Kim, H., Hong, M.-W., Bae, Y.-H., & Lee, S. (2021) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/aiht-2021-72-3555 · Cited by 7
“kr patterns lead to developmental reprogramming, and these epigenetic changes can be inherited through cell division (21).”
BackgroundSUZ12 participates in the proliferation of PNH clones by regulating histone H3K27me3 levels
Chen, Y., Liu, H., Zeng, L., Li, L., Lu, D., Liu, Z., & Fu, R. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a1021-564r · Cited by 7
Metadata
- Authors
- Suvà, M. L., Riggi, N., & Bernstein, B. E.
- Affiliations
- Broad Institute (US)
- Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
- Corresponding author
- Suvà, Mario L.
- Bernstein, Bradley E.
- Venue
- Science
- Published
- 2013-03-29
- Volume
- 339
- Issue
- 6127
- Pages
- 1567-1570
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3821556
- OpenAlex
- W2090757807
- Cited by
- 706
- References
- 64
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 19 · 2023: 40 · 2022: 34 · 2021: 61 · 2020: 62 · 2019: 48 · 2018: 58 · 2017: 72 · 2016: 67 · 2015: 76 · 2014: 85 · 2013: 43
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Environmental Health Sciences (U01ES017155)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- epigenetic reprogramming, cancer, induced pluripotency, transcription factors, chromatin regulators, oncogenic transformation, tumor heterogeneity, cancer stem cells, cell state transitions
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Chromatin, Humans, Neoplasms, Transcription Factors, Neoplastic Stem Cells, DNA Methylation, Pluripotent Stem Cells, Epigenesis, Genetic, Mice, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.